Pets, Perseverance, and Manufacturing Facility Bring Biotech Success

Patricia Lawman, co-founder and CEO of the biotech firm Morphogenesis, a UF startup and UF Innovate | Sid Martin Biotech graduate company, has always been amazed at how our bodies can defeat illnesses and usually do it better than drugs. “In my younger days, it seemed the only things we had available for most diseases were drugs that addressed the symptoms of a disease, not the disease itself,” says Lawman. “I often wondered why we couldn’t figure out a way to help our bodies do what they do best — maintain health and fight disease.”

To pursue that idea, Lawman and her husband Michael founded Morphogenesis, an emerging biotech that is developing personalized immunotherapies for the treatment of cancer. Both were basic scientists with no background in the pharma industry. Michael has a Ph.D. in cell biology and immunology and spent some time with a veterinary research company. Patricia’s background is in molecular biology, immunology, and medical microbiology.

Learn more about Pets, Perseverance, and Manufacturing Facility Bring Biotech Success.